{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:23:44Z","timestamp":1787909024557,"version":"build-2784847793"},"reference-count":64,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074269"],"award-info":[{"award-number":["82074269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.heliyon.2024.e38771","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T21:02:36Z","timestamp":1728075756000},"page":"e38771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of integrated traditional Chinese and Western medicine for rheumatoid arthritis-interstitial lung disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Peipei","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongde","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6474-9198","authenticated-orcid":false,"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.heliyon.2024.e38771_bib1","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"Mcinnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38771_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.55563\/clinexprheumatol\/j1l5l3","article-title":"One year in review 2021: pathogenesis of rheumatoid arthritis","volume":"39","author":"Testa","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38771_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102776","article-title":"Rheumatoid arthritis: extra-articular manifestations and comorbidities","volume":"20","author":"Figus","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.heliyon.2024.e38771_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.109929","article-title":"Hypoxia-induced ALKBH5 aggravates synovial aggression and inflammation in rheumatoid arthritis by regulating the m6A modification of CH25H","volume":"261","author":"Fan","year":"2024","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38771_bib5","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10354","key":"10.1016\/j.heliyon.2024.e38771_bib6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"Wijsenbeek","year":"2022","journal-title":"Lancet (London, England)"},{"issue":"150","key":"10.1016\/j.heliyon.2024.e38771_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0076-2018","article-title":"Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Cottin","year":"2018","journal-title":"Eur. Respir. Rev. : an official journal of the European Respiratory Society"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38771_bib8","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/09031936.00019210","article-title":"Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome","volume":"37","author":"Tsuchiya","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38771_bib9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.heliyon.2024.e38771_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/759760","article-title":"The multifaceted aspects of interstitial lung disease in rheumatoid arthritis","volume":"2013","author":"Cavagna","year":"2013","journal-title":"BioMed Res. Int."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38771_bib11","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38771_bib12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s42358-021-00209-0","article-title":"Lung involvement prevalence in patients with early rheumatoid arthritis without known pulmonary disease: a multicentric cross sectional study","volume":"61","author":"Paulin","year":"2021","journal-title":"Advances in rheumatology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38771_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/BOR.0000000000000787","article-title":"Interstitial lung disease throughout the rheumatoid arthritis disease course","volume":"33","author":"Mcdermott","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e38771_bib14","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology"},{"issue":"19","key":"10.1016\/j.heliyon.2024.e38771_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914509","article-title":"Etiology and pathogenesis of rheumatoid arthritis-interstitial lung disease","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38771_bib16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e38771_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e38771_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.837133","article-title":"Interstitial lung disease in rheumatoid arthritis: a practical review","volume":"9","author":"Laria","year":"2022","journal-title":"Front. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38771_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/17476348.2022.2089116","article-title":"Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies","volume":"16","author":"Diesler","year":"2022","journal-title":"Expet Rev. Respir. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38771_bib20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.38322","article-title":"Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials","volume":"66","author":"Conway","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e38771_bib21","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/rheumatology\/keac651","article-title":"Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease","volume":"62","author":"Kim","year":"2023","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38771_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9041082","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: lights and shadows","volume":"9","author":"Cassone","year":"2020","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38771_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MAJ.0b013e31824c07e8","article-title":"Infliximab-induced nonspecific interstitial pneumonia","volume":"344","author":"Sen","year":"2012","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.heliyon.2024.e38771_bib24","series-title":"WHO Traditional Medicine Strategy: 2014-2023","year":"2013"},{"issue":"26","key":"10.1016\/j.heliyon.2024.e38771_bib25","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2174\/1381612828666220324124720","article-title":"Circumstantial insights into the potential of traditional Chinese medicinal plants as a therapeutic approach in rheumatoid arthritis","volume":"28","author":"Sharma","year":"2022","journal-title":"Curr. Pharmaceut. Des."},{"issue":"Pt A","key":"10.1016\/j.heliyon.2024.e38771_bib26","article-title":"Therapeutic potential of traditional Chinese medicine for interstitial lung disease","volume":"318","author":"Zhou","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e38771_bib27","first-page":"161","article-title":"Observation on the curative effect of Yangyin Yiqi Huoxue decoction on patients with connective tissue disease-associated interstitial lung disease","volume":"21","author":"Li","year":"2019","journal-title":"Liaoning Univ Tradit Chin Med"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e38771_bib28","first-page":"1213","article-title":"Clinical observation on Bufei Tongluo wan combined with methotrexate for rheumatoid arthritis associated early interstitial lung disease: a 32 cases report 2011.14.029","volume":"52","author":"Xie","year":"2011","journal-title":"Tradit. Chin. Med."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38771_bib29","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.heliyon.2024.e38771_bib30","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.heliyon.2024.e38771_bib31","series-title":"Assessing Risk of Bias in a Randomized Trial [J]","first-page":"205","author":"Higgins","year":"2019"},{"key":"10.1016\/j.heliyon.2024.e38771_bib32","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical research ed)"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38771_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e15833","article-title":"Is glucocorticoid use associated with a higher clinical pregnancy rate of in vitro fertilization and embryo transfer? A meta-analysis","volume":"9","author":"Lv","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.heliyon.2024.e38771_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114342","article-title":"A systematic review with meta-analysis on the antihypertensive efficacy of Nigerian medicinal plants","volume":"279","author":"Abdulazeez","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"7414","key":"10.1016\/j.heliyon.2024.e38771_bib35","first-page":"557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.heliyon.2024.e38771_bib36","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins J P T A G","year":"2011"},{"issue":"22","key":"10.1016\/j.heliyon.2024.e38771_bib37","first-page":"48","article-title":"Radix Paeonia lactiflora totalis in the treatment of rheumatoid arthritis combined with interstitial lung disease Clinical efficacy and changes in patients' lung function","volume":"59","author":"Duan","year":"2019","journal-title":"Shandong Med. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38771_bib38","first-page":"8","article-title":"Clinical efficacy of Tetrandrine and Cyclophosphamide in treatment of rheumatoid arthritis complicated with interstitial lung disease","volume":"28","author":"Chen","year":"2022","journal-title":"Chin. J. Biomed. Eng."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38771_bib39","first-page":"2896","article-title":"Clinical effects of Tripterygium wilfordii Polyglycoside Tablets on patients with rheumatoid arthritis complicated with interstitial lung disease","volume":"45","author":"Li","year":"2023","journal-title":"Chin. Tradit. Pat. Med."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e38771_bib40","first-page":"227","article-title":"Clinical study on treatment of rheumatoid arthritis associated interstitial lung disease by fangxian decoction","volume":"17","author":"Li","year":"2011","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e38771_bib41","first-page":"1213","article-title":"Observation on bufei tongluo wan combined with methotrexate for rheumatoid arthritis associated early interstitial lung disease: a32 cases report","volume":"52","year":"2011","journal-title":"J. Tradit. Chin. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38771_bib42","first-page":"41","article-title":"Clinical study on rheumatoid arthritis-interstitial lung disease treated with Shengxian Bolus and Cyclophosphamide Pulse therapy","volume":"34","author":"Zhang","year":"2014","journal-title":"Jilin Journal of Traditional Chinese Medicine"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38771_bib43","first-page":"2030","article-title":"Clinical emcacy of Chenshi Qingfei Decoction on rheumatoid arthritis and interstitial Iung disease","volume":"39","author":"Tang","year":"2017","journal-title":"Chin. Tradit. Pat. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e38771_bib44","first-page":"185","article-title":"Clinical observation of yiqi yangyin tongbi prescription on rheumatoid arthritis and pulmonary interstitial lesions","volume":"23","author":"Wang","year":"2017","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38771_bib45","first-page":"1103","article-title":"Efficacy of self-proposed Yangyin Tongbi formula in treating rheumatoid arthritis combined with interstitial lung lesions and its effect on MMPs and KL-6","volume":"27","author":"Huang","year":"2018","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e38771_bib46","first-page":"1041","article-title":"Brief analysis of Huoxue Tongluo decoction on differentiation and treatment of rheumatoid arthritis with pulmonary interstitial fibrosis","volume":"40","author":"Li","year":"2019","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e38771_bib47","first-page":"1609","article-title":"Research of treating rheumatoid arthritis associated interstitial lung disease with tongbi granules and its effect on TGF-\u03b21 and KL-6","volume":"40","author":"Liu","year":"2020","journal-title":"Jilin Journal of Chinese Medicine"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38771_bib48","first-page":"49","article-title":"Treatment of 30 cases of rheumatoid arthritis related pulmonary interstitial disease with bufei huaxian decoction combined with pirfenidone","volume":"36","author":"Wang","year":"2020","journal-title":"Hunan Journal of Traditional Chinese Medicine"},{"issue":"14","key":"10.1016\/j.heliyon.2024.e38771_bib49","first-page":"111","article-title":"Observation on 47 cases of rheumatoid arthritis complicated with pulmonary interstitial fibrosis treated by lntegrated traditional Chinese and western medicine","volume":"30","year":"2021","journal-title":"Chin. J. Ethnomed. Ethnopharmacy"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e38771_bib50","first-page":"141","article-title":"Decoction on pulmonary function of patients with rheumatoid arthritis complicated with pulmonary interstitial fibrosis","volume":"28","year":"2022","journal-title":"Contemporary Medicine"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e38771_bib51","first-page":"64","article-title":"Efficacy of Qingfei Huayu Decoction combined with pirfenidone on progressive fibrosing interstitial lung disease associated with rheumatoid arthritis of lung heat and blood stasis syndrome type","volume":"56","author":"Yao","year":"2022","journal-title":"Shanghai J. Tradit. Chin. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38771_bib52","first-page":"463","article-title":"Effect of Kangxian decoction combined with prednisone acetate tablet in treatment of rheumatoid arthritis complicated with lung interstitial disease of Qixu Xueyu syndrome","volume":"44","author":"Wang","year":"2023","journal-title":"Shaanxi J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e38771_bib53","first-page":"115","article-title":"Effect of huoxue tongluo decoction on pulmonary interstitial fibrosis caused by rheumatoid arthritis","volume":"51","author":"Qin","year":"2024","journal-title":"Liaoning Journal of Traditional Chinese Medicine"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38771_bib54","first-page":"325","article-title":"41 cases of rheumatoid arthritis-related interstitial pulmonary disease with phlegm-blood stasis syndrome treated with canxiong tongbi decoction","volume":"17","author":"Shao","year":"2024","journal-title":"Global Traditional Chinese Medicine"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e38771_bib55","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17476348.2023.2176303","article-title":"Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements","volume":"17","author":"Kuwana","year":"2023","journal-title":"Expet Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38771_bib56","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38771_bib57","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.13130187","article-title":"Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern","volume":"270","author":"Assayag","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.heliyon.2024.e38771_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101981","article-title":"Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: underlying mechanisms based on cell and molecular targets","volume":"89","author":"Li","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.heliyon.2024.e38771_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pupt.2019.03.011","article-title":"Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK\/STAT\/RANKL signaling pathway","volume":"56","author":"Yang","year":"2019","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.heliyon.2024.e38771_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.990760","article-title":"Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K\/Akt, apoptosis, and TNF-\u03b1 signalling pathways","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e38771_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40265-014-0190-z","article-title":"Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced","volume":"74","author":"Hallowell","year":"2014","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e38771_bib62","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.reuma.2011.12.008","article-title":"Interstitial lung disease related to rheumatoid arthritis: evolution after treatment","volume":"8","author":"Rojas-Serrano","year":"2012","journal-title":"Reumatol. Cl\u00ednica"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e38771_bib63","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e38771_bib64","first-page":"5905","article-title":"Effect of Qingfei Huaxian Decoction combined with prednisone acetate on serum inflammatory factors and pulmonary function of patients with idiopathic pulmonary fibrosis","volume":"14","author":"Zhou","year":"2022","journal-title":"Am. J. Tourism Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024148025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024148025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:17:37Z","timestamp":1775456257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024148025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":64,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2405844024148025"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38771","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of integrated traditional Chinese and Western medicine for rheumatoid arthritis-interstitial lung disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e38771"}}